Vivani Medical VANI Research And Development Tax Incentive Receivable Current
Research And Development Tax Incentive Receivable Current at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept vani:ResearchAndDevelopmentTaxIncentiveReceivableCurrent.
The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's research and development tax incentive receivable current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's research and development tax incentive receivable current?
- Vivani Medical (VANI) reported research and development tax incentive receivable current of $685K in Q1 2026.
- How has Vivani Medical's research and development tax incentive receivable current changed year-over-year?
- Vivani Medical's research and development tax incentive receivable current increased by 291.4% year-over-year, from $175K to $685K.
- What does research and development tax incentive receivable current mean?
- This represents the expected tax credits or refunds receivable from government authorities specifically related to qualifying research and development expenditures. It serves as a near-term liquidity source that offsets the high cash burn typical of preclinical biopharmaceutical development. Monitoring this balance helps investors understand the company's ability to monetize its innovation investments through tax policy.